High resolution solution structure of a DNA duplex alkylated by the antitumor agent duocarmycin SA.

The three-dimensional solution structure of duocarmycin SA in complex with d-(G1ACTAATTGAC11).d-(G12TCATTAGTC22) has been determined by restrained molecular dynamics and relaxation matrix calculations using experimental NOE distance and torsion angle constraints derived from 1H NMR spectroscopy. The final input data consisted of a total of 858 distance and 189 dihedral angle constraints, an average of 46 constraints per residue. In the ensemble of 20 final structures, there were no distance constraint violations >0.06 A or torsion angle violations >0.8 degrees. The average pairwise root mean square deviation (RMSD) over all 20 structures for the binding site region is 0.57 A (average RMSD from the mean: 0.39 A). Although the DNA is very B-like, the sugar-phosphate backbone torsion angles beta, epsilon, and zeta are distorted from standard values in the binding site region. The structure reveals site-specific bonding of duocarmycin SA at the N3 position of adenine 19 in the AT-rich minor groove of the duplex and binding stabilization via hydrophobic interactions. Comparisons have been made to the structure of a closely related complex of duocarmycin A bound to an AT-rich DNA duplex. These results provide insights into critical aspects of the alkylation site selectivity and source of catalysis of the DNA alkylating agents, and the unusual stability of the resulting adducts.

[1]  D. Boger,et al.  Catalysis of the CC-1065 and duocarmycin DNA alkylation reaction: DNA binding induced conformational change in the agent results in activation. , 1997, Bioorganic & medicinal chemistry.

[2]  D. Case,et al.  Molecular Dynamics Docking Driven by NMR‐Derived Restraints to Determine the Structure of the Calicheamicin γ1I Oligosaccharide Domain Complexed to Duplex DNA , 1996 .

[3]  D. Boger,et al.  Examination of the role of the duocarmycin SA methoxy substituents: Identification of the minimum, fully potent DNA binding subunit , 1996 .

[4]  D. Boger,et al.  A comparative study of the solvolysis reactivity, regioselectivity, and stereochemistry of the duocarmycin a and sa alkylation subunits , 1996 .

[5]  D. Boger,et al.  CC-1065 AND THE DUOCARMYCINS : UNDERSTANDING THEIR BIOLOGICAL FUNCTION THROUGH MECHANISTIC STUDIES , 1996 .

[6]  D E Wemmer,et al.  Interproton distance bounds from 2D NOE intensities: Effect of experimental noise and peak integration errors , 1995, Journal of biomolecular NMR.

[7]  Jean-Claude Spehner,et al.  Fast and robust computation of molecular surfaces , 1995, SCG '95.

[8]  D. Boger The Duocarmycins: Synthetic and Mechanistic Studies , 1995 .

[9]  D. Patel,et al.  Solution structure of the covalent duocarmycin A-DNA duplex complex. , 1995, Journal of molecular biology.

[10]  W. Chazin,et al.  Determination of the solution structure of Apo calbindin D9k by NMR spectroscopy. , 1995, Journal of molecular biology.

[11]  D. Boger,et al.  (+)- and ent-(-)-Duocarmycin SA and (+)- and ent-(-)-N-BOC-DSA DNA Alkylation Properties.Alkylation Site Models That Accommodate the Offset AT-Rich Adenine N3 Alkylation Selectivity of the Enantiomeric Agents , 1994 .

[12]  D. Boger,et al.  Reversibility of the duocarmycin A and SA DNA alkylation reaction , 1993 .

[13]  D. Patel,et al.  Site-specific covalent duocarmycin A-intramolecular DNA triplex complex , 1992 .

[14]  T. James,et al.  Solution structure of a DNA octamer containing the Pribnow box via restrained molecular dynamics simulation with distance and torsion angle constraints derived from two-dimensional nuclear magnetic resonance spectral fitting. , 1992, Journal of molecular biology.

[15]  B. Reid,et al.  Determination of nucleic acid backbone conformation by proton nmr , 1992 .

[16]  W. Chazin,et al.  Comparative NMR analysis of the decadeoxynucleotide d-(GCATTAATGC)2 and an analogue containing 2-aminoadenine. , 1991, Nucleic Acids Research.

[17]  D. Patel,et al.  Heteronuclear two‐dimensional 15N‐ and 13C‐nmr studies of DNA oligomers and their netropsin complexes using indirect proton detection , 1991, Biopolymers.

[18]  D. Boger,et al.  Duocarmycin-pyrindamycin DNA alkylation properties and identification, synthesis, and evaluation of agents incorporating the pharmacophore of the duocarmycin-pyrindamycin alkylation subunit. Identification of the CC-1065 duocarmycin common pharmacophore , 1990 .

[19]  C. H. Lin,et al.  Determination of the major tautomeric form of the covalently modified adenine in the (+)-CC-1065-DNA adduct by 1H and 15N NMR studies. , 1990, Biochemistry.

[20]  B. Borgias,et al.  MARDIGRAS : a procedure for matrix analysis of relaxation for discerning geometry of an aqueous structure , 1990 .

[21]  T. Scahill,et al.  An NMR study of the covalent and noncovalent interactions of CC-1065 and DNA. , 1990, Biochemistry.

[22]  R. S. Coleman,et al.  Natural and Synthetic Antitumor Agents: Synthetic Studies on CC-1065 and Functionally Related Agents , 1990 .

[23]  R. S. Coleman,et al.  A demonstration of the intrinsic importance of stabilizing hydrophobic binding and non-covalent van der Waals contacts dominant in the non-covalent CC-1065/B-DNA binding. , 1990, Chemico-biological interactions.

[24]  P. Dervan,et al.  Sequence-specific cleavage of DNA by N-bromoacetyldistamycin. Product and kinetic analyses , 1989 .

[25]  D. G. Davis Elimination of baseline distortions and minimization of artifacts from phased 2D NMR spectra , 1989 .

[26]  B. Borgias,et al.  Two-dimensional nuclear Overhauser effect: complete relaxation matrix analysis. , 1989, Methods in enzymology.

[27]  A. Bax,et al.  P.COSY, a sensitive alternative for double-quantum-filtered COSY , 1988 .

[28]  C. W. Hilbers,et al.  Nucleic acids and nuclear magnetic resonance. , 1988, European journal of biochemistry.

[29]  M. Warpehoski,et al.  Sequence selectivity of DNA covalent modification. , 1988, Chemical research in toxicology.

[30]  A. J. Shaka,et al.  Iterative schemes for bilinear operators; application to spin decoupling , 1988 .

[31]  Atta-ur- Rahman,et al.  Studies in natural products chemistry , 1988 .

[32]  M. Rance Improved techniques for homonuclear rotating-frame and isotropic mixing experiments , 1987 .

[33]  B. Reid Sequence-specific assignments and their use in NMR studies of DNA structure , 1987, Quarterly Reviews of Biophysics.

[34]  D. Patel,et al.  DNA and RNA: NMR studies of conformations and dynamics in solution , 1987, Quarterly Reviews of Biophysics.

[35]  G. A. van der Marel,et al.  An NMR study of the polymorphous behavior of the mismatched DNA octamer d(m5C-G-m5C-G-T-G-m5C-G) in solution. The B, Z, and hairpin forms. , 1987, Journal of biomolecular structure & dynamics.

[36]  L. Mueller P.E.COSY, a simple alternative to E.COSY , 1987 .

[37]  G. Wagner,et al.  Assignment of the 13C nuclear magnetic resonance spectrum of a short DNA-duplex with 1H-detected two-dimensional heteronuclear correlation spectroscopy , 1987, Nucleic Acids Res..

[38]  W. Saenger,et al.  DNA-ligand interactions : from drugs to proteins , 1987 .

[39]  B. Lambert,et al.  Pharmacology of DNA Binding Drugs , 1987 .

[40]  D. Patel,et al.  Nuclear magnetic resonance and distance geometry studies of DNA structures in solution. , 1987, Annual review of biophysics and biophysical chemistry.

[41]  K. Wüthrich NMR of proteins and nucleic acids , 1988 .

[42]  K. Wüthrich,et al.  1H nuclear magnetic resonance assignments for d-(GCATTAATGC)2 using experimental refinements of established procedures. , 1986, Journal of molecular biology.

[43]  L. Hurley,et al.  Covalent Binding of Antitumor Antibiotics in the Minor Groove of DNA. Mechanism of Action of CC-1065 and the Pyrrolo (1,4) benzodiazepines , 1986 .

[44]  L. Hurley,et al.  The chemistry, mechanism of action and biological properties of CC-1065, a potent antitumor antibiotic. , 1986, The Journal of antibiotics.

[45]  C Zimmer,et al.  Nonintercalating DNA-binding ligands: specificity of the interaction and their use as tools in biophysical, biochemical and biological investigations of the genetic material. , 1986, Progress in biophysics and molecular biology.

[46]  Ad Bax,et al.  MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy , 1985 .

[47]  B. Reid,et al.  High Resolution NMR Studies of Nucleic Acids and Proteins , 1985 .

[48]  L. Hurley,et al.  Reaction of the antitumor antibiotic CC-1065 with DNA: structure of a DNA adduct with DNA sequence specificity. , 1984, Science.

[49]  Richard R. Ernst,et al.  Coherence transfer by isotropic mixing: Application to proton correlation spectroscopy , 1983 .

[50]  K. Wüthrich,et al.  Application of phase sensitive two-dimensional correlated spectroscopy (COSY) for measurements of 1H-1H spin-spin coupling constants in proteins. , 1983, Biochemical and biophysical research communications.

[51]  M. Rance,et al.  Obtaining high-fidelity spin-12 powder spectra in anisotropic media: Phase-cycled Hahn echo spectroscopy , 1983 .

[52]  G. Bodenhausen,et al.  Analysis of networks of coupled spins by multiple quantum N.M.R. , 1983 .

[53]  Pierre Plateau,et al.  Exchangeable proton NMR without base-line distorsion, using new strong-pulse sequences , 1982 .

[54]  C. Altona,et al.  Thermodynamics of Stacking and of Self‐Association of the Dinucleoside Monophosphate m62A‐U from Proton NMR Chemical Shifts: , 1982 .

[55]  D. V. Von Hoff,et al.  CC-1065 (NSC 298223), a most potent antitumor agent: kinetics of inhibition of growth, DNA synthesis, and cell survival. , 1982, Cancer research.

[56]  W. C. Krueger,et al.  CC-1065 (NSC 298223), a potent new antitumor agent improved production and isolation, characterization and antitumor activity. , 1981, The Journal of antibiotics.

[57]  Richard R. Ernst,et al.  Elucidation of cross relaxation in liquids by two-dimensional N.M.R. spectroscopy , 1980 .